Discover 1,564 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,564
Active & Responsive
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: Inwood NY, The Bronx NY, Princeton NJ, Toms River NJ,
Sponsor: Neumora Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06058013
Phase3, Recruiting
Active & ResponsiveNew
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
for
Influenza
Location: Brooklyn NY, The Bronx NY, Hartsdale NY,
Sponsor: Cidara Therapeutics Inc.
Sex: All
Age: 12+
Code: NCT07159763
Phase3, Recruiting
Active & ResponsiveNew
Rutgers University Study of the Genetics of Breast Cancer.
for
Breast Cancer Risk, Breast Cancer Prevention, Breast Cancer
Location: Piscataway NJ
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT06773897
Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Hoboken NJ, New York NY, Camp Hill PA, Arlington VA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06863961
Phase2, Recruiting
Active & Responsive
A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
for
Asthma
Location: Jersey City NJ, Horsham PA, Philadelphia PA,
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Sex: All
Age: 12+
Code: NCT06664619
Phase3, Recruiting
Active & Responsive
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
for
Recurrent Endometrial Carcinoma,
Location: Jersey City NJ, New York NY, Middletown NJ, Harrison NY,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT05554328
Phase2, Recruiting
Active & Responsive
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: New York NY, Mineola NY, Willow Grove PA,
Sponsor: Celgene
Sex: Male
Age: 18+
Code: NCT06764485
Phase3, Recruiting
Active & Responsive
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
for
Relapsing Multiple Sclerosis (RMS)
Location: New York NY, Hackensack NJ, Teaneck NJ, Neptune City NJ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06869785
Phase3, Recruiting
Active & Responsive
WATER IV Prostate Cancer
for
Localized Prostate Cancer
Location: New York NY, Hackensack NJ, Alexandria VA, Montreal,